I ordered a vial from a Canadian supplier in late spring and committed to giving it a proper trial
In another 2006 clinical trial,(10)72 test subjects with pressure ulcers were presented with TB-500. The main aim of this randomized, double blind study was to establish the potential of thymosin beta 4 (analogous to TB-500) in ulcer presence
TB-500 / Thymosin Beta-4 (10 mg) In plain terms: TB-500 relates to thymosin beta-4, a protein involved in how cells build and dismantle their internal scaffolding
GHK-Cu promotes angiogenesis, the formation of new blood vessels
Readers sometimes prefer a higher concentration to reduce injection volume, but the tradeoff in measurement accuracy is rarely worth it, especially for those new to subcutaneous injections
By possibly reversing some of the damages typically associated with neurodegenerative conditions, dihexa offers hope for improving the quality of life for patients with such diagnoses